BLISIBIMOD
UNII 114VP6C6ES

Substance Identification & Data

This profile provides standardized clinical and technical data for Blisibimod, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 114VP6C6ES.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1236126-45-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
114VP6C6ES
CAS Registry Number
1236126-45-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BLISIBIMOD
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
9583
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
YY-97
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Blisibimod. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BLISIBIMOD

Common Names & Synonyms

BLISIBIMOD [INN]
BLISIBIMOD [USAN]
BLISIBIMOD [WHO-DD]
PROTEIN (SYNTHETIC CYTOKINE BAFF-BINDING DOMAIN FRAGMENT) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN FC FRAGMENT), DIMER

Technical Codes

A-623
AMG 623
AMG-623